TScan Therapeutics (TCRX) EBIT Margin (2020 - 2026)
TScan Therapeutics' EBIT Margin was -5636.69% in Q3 2026, down 4161.10 percentage points from -1475.59% a year earlier and down 2735.36 percentage points from the prior quarter.
TScan Therapeutics (TCRX) EBIT Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, TScan Therapeutics' EBIT Margin was -2246.84% through Sep 30, 2026, down 481.83 percentage points year-over-year; for FY2025, it was -1315.38%, up 3472.30 percentage points from FY2024.
- EBIT Margin shows a five-year change of +1102.41 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was -4787.68% in FY2024 (-4343.68 pp), -444.00% in FY2023 (+48.32 pp), -492.32% in FY2022 (-12.68 pp) and -479.65% in FY2021 (+1938.14 pp).
- The Q3 2026 figure marks the lowest quarterly EBIT Margin since Q2 2024.
- Compared with a year earlier, EBIT Margin has declined for three straight quarters, with an average year-over-year change of +359.84 percentage points over the last eight quarters.
- The best year-over-year quarter for EBIT Margin over five years was Q2 2025 (a gain of 5107.95 percentage points); the worst was Q2 2024 (a drop of 5582.79 percentage points).
- Per Business Quant data, TCRX's EBIT Margin in the three quarters before Q3 2026 was -2901.33% (Q2 2026), -2967.31% (Q1 2026) and -929.41% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -907.40% |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 34.46% |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 24.35% |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 36.01% |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 30.74% |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 41.71% |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | TScan Therapeutics | 18.87 Mn | -434.83 Mn | - | -5,636.69% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -5,636.69% |
| Jun 30, 2026 | -2,901.33% |
| Mar 31, 2026 | -2,967.31% |
| Dec 31, 2025 | -929.41% |
| Sep 30, 2025 | -1,475.59% |
| Jun 30, 2025 | -1,256.60% |
| Mar 31, 2025 | -1,669.74% |
| Dec 31, 2024 | -5,520.60% |
| Sep 30, 2024 | -3,109.82% |
| Jun 30, 2024 | -6,364.55% |
| Mar 31, 2024 | -5,542.93% |
| Dec 31, 2023 | -296.17% |
| Sep 30, 2023 | -636.69% |
| Jun 30, 2023 | -781.77% |
| Mar 31, 2023 | -334.31% |
| Dec 31, 2022 | -602.55% |
| Sep 30, 2022 | -492.95% |
| Jun 30, 2022 | -375.89% |
| Mar 31, 2022 | -535.02% |
| Dec 31, 2021 | -497.62% |
TScan Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=TCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();